甲状腺髓癌:瘤微环境的分子驱动因素和免疫细胞环境 - - 对全身治疗的影响
Alexander J Papachristos1,2, Hazel Serrao-Brown2, Anthony J Gill1,3,4
1Northern Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia.
Cancers
|July 13, 2024
概括
骨髓性甲状腺癌 (MTC) 具有较低的瘤突变负担,限制了免疫治疗. 有针对性的RET抑制剂显示出有希望的结果,但耐药性机制需要进一步研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 甲状腺髓性癌 (MTC) 是由特定的遗传变异驱动的.
- 与其他癌症相比,MTC表现出异常低的瘤突变负担 (TMB).
研究的目的:
- 审查MTC的分子生物学及其与免疫系统的相互作用.
- 了解低TMB对MTC免疫疗法疗效的影响.
主要方法:
- 对MTC分子遗传学和免疫学现有文献的审查.
- 在MTC中分析瘤突变负担 (TMB) 和新抗原呈现.
- 对MTC的向疗法的评估,包括RET抑制剂.
主要成果:
- 在MTC中低的TMB导致较少的新抗原,可能减少抗瘤免疫反应.
- 特定的RET致病变体驱动MTC,解释了RET特定的氨酸激酶抑制剂 (TKI) 的疗效.
结论:
- 由于TMB和新抗原呈现较低,MTC中的免疫治疗疗效可能受到限制.
- 向RET抑制剂是有效的,但治疗耐久性受到抵抗机制的挑战.
- 需要进一步的研究,以克服MTC中途径抑制剂的耐药性.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886